Ana Westenberger
Ana Westenberger
Verified email at
Cited by
Cited by
Genetics of Parkinson’s disease
C Klein, A Westenberger
Cold Spring Harbor perspectives in medicine 2 (1), a008888, 2012
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study
OA Ross, AI Soto-Ortolaza, MG Heckman, JO Aasly, N Abahuni, G Annesi, ...
The Lancet Neurology 10 (10), 898-908, 2011
Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice
A Keller, A Westenberger, MJ Sobrido, M Garcia-Murias, A Domingo, ...
Nature genetics 45 (9), 1077-1082, 2013
DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease
K Hedrich, A Djarmati, N Schäfer, R Hering, C Wellenbrock, PH Weiss, ...
Neurology 62 (3), 389-394, 2004
The evolving spectrum of PRRT2-associated paroxysmal diseases
D Ebrahimi-Fakhari, A Saffari, A Westenberger, C Klein
Brain 138 (12), 3476-3495, 2015
Genotype‐Phenotype Relations for the Parkinson's Disease Genes Parkin, PINK1, DJ1: MDSGene Systematic Review
M Kasten, C Hartmann, J Hampf, S Schaake, A Westenberger, ...
Movement Disorders 33 (5), 730-741, 2018
Mutations in THAP1 (DYT6) and generalised dystonia with prominent spasmodic dysphonia: a genetic screening study
A Djarmati, SA Schneider, K Lohmann, S Winkler, H Pawlack, J Hagenah, ...
The Lancet Neurology 8 (5), 447-452, 2009
Ube2w and ataxin-3 coordinately regulate the ubiquitin ligase CHIP
KM Scaglione, E Zavodszky, SV Todi, S Patury, P Xu, ...
Molecular cell 43 (4), 599-612, 2011
PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism
C Klein, A Djarmati, K Hedrich, N Schäfer, C Scaglione, R Marchese, ...
European journal of human genetics 13 (9), 1086-1093, 2005
The Machado–Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability
TM Durcan, M Kontogiannea, T Thorarinsdottir, L Fallon, AJ Williams, ...
Human molecular genetics 20 (1), 141-154, 2011
Large-scale replication and heterogeneity in Parkinson disease genetic loci
M Sharma, JPA Ioannidis, JO Aasly, G Annesi, A Brice, ...
Neurology 79 (7), 659-667, 2012
Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit?
K Hedrich, J Hagenah, A Djarmati, A Hiller, T Lohnau, K Lasek, ...
Archives of neurology 63 (6), 833-838, 2006
Genetics and pathophysiology of neurodegeneration with brain iron accumulation (NBIA)
S A Schneider, P Dusek, J Hardy, A Westenberger, J Jankovic, K P Bhatia
Current neuropharmacology 11 (1), 59-79, 2013
Myoclonus‐dystonia: significance of large SGCE deletions
A Grünewald, A Djarmati, K Lohmann‐Hedrich, K Farrell, JA Zeller, ...
Human mutation 29 (2), 331-332, 2008
Phenotypic insights into ADCY5‐associated disease
FCF Chang, A Westenberger, RC Dale, M Smith, HS Pall, ...
Movement Disorders 31 (7), 1033-1040, 2016
Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early‐onset Parkinson disease: Parkin mutation frequency depends on ethnic origin of patients
A Djarmati, K Hedrich, M Svetel, N Schäfer, V Juric, S Vukosavic, ...
Human mutation 23 (5), 525-525, 2004
Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype
N Brüggemann, J Hagenah, K Reetz, A Schmidt, M Kasten, I Buchmann, ...
Archives of neurology 67 (11), 1357-1363, 2010
Genetics of Parkinson's disease
KR Kumar, A Djarmati-Westenberger, A Grünewald
Seminars in neurology 31 (05), 433-440, 2011
Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations
S Steinlechner, J Stahlberg, B Völkel, A Djarmati, J Hagenah, A Hiller, ...
Journal of Neurology, Neurosurgery & Psychiatry 78 (5), 532-535, 2007
A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease
R Krüger, M Sharma, O Riess, T Gasser, C Van Broeckhoven, J Theuns, ...
Neurobiology of aging 32 (3), 548. e9-548. e18, 2011
The system can't perform the operation now. Try again later.
Articles 1–20